05/02/2024
5:07 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
5:03 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
4:23 PM | Aurinia Pharmaceuticals (Subject)
ILJIN SNT Co., Ltd. (Filed by)
| Form SC 13D/A | |
03/07/2024
3:44 PM | Aurinia Pharmaceuticals (Issuer)
Miller Joseph M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:46 PM | Aurinia Pharmaceuticals (Issuer)
Greenleaf Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:41 PM | Aurinia Pharmaceuticals (Issuer)
Robertson Stephen P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:42 PM | Aurinia Pharmaceuticals (Issuer)
Habig Scott Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/07/2024
3:43 PM | Aurinia Pharmaceuticals (Issuer)
Donley Matthew Maxwell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:10 PM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:11 PM | Aurinia Pharmaceuticals (Issuer)
Knappertz Volker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:31 PM | Aurinia Pharmaceuticals (Issuer)
Donley Matthew Maxwell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:33 PM | Aurinia Pharmaceuticals (Issuer)
Habig Scott Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:35 PM | Aurinia Pharmaceuticals (Issuer)
Knappertz Volker (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:17 PM | Aurinia Pharmaceuticals (Issuer)
Miller Joseph M (Reporting)
| Form 4/A | |
02/22/2024
3:19 PM | Aurinia Pharmaceuticals (Issuer)
Robertson Stephen P. (Reporting)
| Form 4/A | |
02/15/2024
5:06 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
5:16 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
2:27 PM | ARMISTICE CAPITAL, LLC (Filed by)
Aurinia Pharmaceuticals (Subject)
| Form SC 13G | |
02/12/2024
8:41 AM | Aurinia Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/05/2024
5:02 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
5:01 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
5:05 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/22/2023
3:36 PM | Aurinia Pharmaceuticals (Issuer)
Foster Robert T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/22/2023
3:31 PM | Aurinia Pharmaceuticals (Issuer)
Foster Robert T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/21/2023
3:06 PM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
3:16 PM | Aurinia Pharmaceuticals (Issuer)
Smith Karen L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2023
3:19 PM | Aurinia Pharmaceuticals (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
3:21 PM | Aurinia Pharmaceuticals (Issuer)
Bailey Jeffrey Allen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/21/2023
3:25 PM | Aurinia Pharmaceuticals (Issuer)
Bailey Jeffrey Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
5:03 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
5:07 AM | Aurinia Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/06/2023
7:33 AM | Aurinia Pharmaceuticals (Subject)
MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
07/03/2023
5:06 AM | Aurinia Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
1:01 PM | Aurinia Pharmaceuticals (Subject)
MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
05/26/2023
3:39 PM | Aurinia Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/23/2023
4:14 PM | Aurinia Pharmaceuticals (Issuer)
Leversage Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:16 PM | Aurinia Pharmaceuticals (Issuer)
MacKay-Dunn R. Hector (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:16 PM | Aurinia Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:17 PM | Aurinia Pharmaceuticals (Issuer)
Billen Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:18 PM | Aurinia Pharmaceuticals (Issuer)
Hagan Joseph P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:19 PM | Aurinia Pharmaceuticals (Issuer)
Jayne David R.W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Department of Defense Has a New Drone Contractor (Ad) The Department of Defense just granted a major advantage to a small UAV provider.
Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes. Click here to see how to invest |
05/23/2023
4:22 PM | Aurinia Pharmaceuticals (Issuer)
Balakrishnan Brinda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
3:00 PM | Aurinia Pharmaceuticals (Subject)
MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
05/11/2023
10:34 AM | Aurinia Pharmaceuticals (Subject)
MKT Capital Ltd. (Filed by)
| Form PX14A6G | |
05/10/2023
3:30 PM | Aurinia Pharmaceuticals (Subject)
ILJIN SNT Co., Ltd. (Filed by)
| Form SC 13D/A | |
